Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Intercellular Sciences Releases New Case Study on Stem Cell Treatment and its Effects on Strokes
  • USA - English


News provided by

Intercellular Sciences

Jul 08, 2013, 18:00 ET

Share this article

Share toX

Share this article

Share toX

John and Karen. John received stem cell treatment by Intercellular Sciences.
John and Karen. John received stem cell treatment by Intercellular Sciences.

Bonita Springs, FL (PRWEB) July 08, 2013 -- Karen Anderson was hoping that her husband John, 62, would see an improvement in his damaged heart following stem cell treatment in the Dominican Republic, and he did. His heart function improved and he was able to return to how he was before his heart went bad.

Since these stem cells are the body’s natural healing cells, some of those stem cells go to other parts of the body and start to repair damage, says Dr. Zannos G. Grekos.

Post this

What Karen didn’t expect was that his stroke would get better too. So much better that he can now drive for the first time since his stroke. “John’s response to the stem cell treatment has just been amazing, nothing short of a miracle,” Karen says. John had been struggling with severe deficits since his stroke two and a half years ago. He could not finish a sentence, do simple math, write words or even say his wife’s name correctly. Now he can carry on conversations, add up the tip on a restaurant bill and most impressively – safely drive the family car, which became very important when Karen broke her foot and John had to drive her around.

“I never thought our roles would reverse and John would be taking care of me, but thanks to his stem cell therapy he is returning back to the man he was.” Karen’s big smile says it all.

Strokes are usually blood clots that travel to the brain, block an artery and cause loss of brain function and paralysis. Stroke is a leading cause of death in the United States, killing nearly 130,000 Americans each year—that’s 1 of every 18 deaths. This is devastating to not only the patient but also to their family.

John C. (age 62, Dickson, TN), has had Cardiomyopathy (weak heart) since he was a young man. First diagnosed while in college, he has had to adjust his life style, adapting it to his weak heart function. His doctors recommended a defibrillator a few years ago and he has been dependent on it ever since. Then, in 2010, he suffered a massive stroke which left him quite disabled. His heart symptoms also rapidly worsened. Due to severe shortness of breath and fatigue, he had to stop many of his activities; even walking up his driveway had become impossible. John’s heart ejection fraction (the percent of pumping of the heart) had dropped to under 10%. His doctors were not optimistic. He and his wife Karen refused to accept such a grim fate and searched for alternative treatment. They soon found an option: adult stem cell therapy.

Zannos Grekos MD, MAAC, FACC, chief science officer of Intercellular Sciences and a Florida-based pioneer in the field of adult stem cell therapy describes how stem cells from the patient are extracted and activated in a laboratory. These cells we call Regenocytes.” Dr. Zannos G. Grekos explains how, in this groundbreaking treatment, cardiologist Doctor Hector Rosario, Chief of Interventional Therapy for Intercellular Sciences, inserts a catheter into the patient’s heart similar to a heart catheterization to inject the stem cells. The process of tissue repairing the damaged heart begins almost immediately. “Since these stem cells are the body’s natural healing cells, some of those stem cells go to other parts of the body and start to repair damage. When this happens we can see some amazing improvement in areas we hadn’t targeted. Things like arthritis or diabetes get better, even stroke symptoms like in this patient” says Grekos, who has been treating patients with stem cells since 2006.

“I have much more energy now,” said John after his treatment. “I’m back to walking the perimeter of my 6 acre property and back at cardiac rehab. I have even started bowling again which I had stopped.” An echocardiogram performed by his cardiologist 3 months after his treatment showed that his heart function had doubled.

ABOUT ZANNOS GREKOS, MD, MAAC, FACC:

Dr. Zannos Grekos is an Interventional Cardiologist and specialist in stem cell research and treatment. Dr. Grekos has extensive experience in the field of stem cell therapy. In collaboration with major treatment and research centers, he has developed many of the protocols used for adult stem cell therapy throughout the world. Dr. Zannos Grekos also trains physicians in the evaluation and treatment of patients receiving stem cell therapy. He was appointed to the Science Advisory Board of the United States' Repair Stem Cell Institute. Dr. Zannos Grekos was invited to Washington, DC to brief the United States Senate Health Advisory staff in 2007. Dr Grekos lectures and educates both nationally and internationally on the current clinical status of stem cell therapy.

Dr. Zannos Grekos and the Intercellular Sciences medical team continue to research the impact of adult stem cell therapy on disease. Intercellular Science specializes in heart disease treatment and lung diseases treatment as well as stem cell treatment for neurologic disease. For more information on Intercellular Sciences Adult Stem Cell procedures, upcoming seminars, and to see videos featuring treated patients, visit http://www.regenocyte.com.

About Intercellular Sciences:

Intercellular Sciences is an international company based in Bonita Springs, Florida. Dedicated to leading the world in providing adult stem cell therapies, Intercellular utilizes the safest and most effective technologies and medical procedures to prolong and improve the lives of its patients. To see more cases by Intercellular Sciences, please visit our website at http://www.regenocyte.com.

Mike Calcaterra, Intercellular Sciences, http://www.regenocyte.com, 239-498-9114, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.